title: Smoking topography and abstinence in adult female smokers.
abstract: Preliminary evidence, within both adults and adolescents, suggests that the intensity with which cigarettes are smoked (i.e., smoking topography) is predictive of success during a cessation attempt. These reports have also shown topography to be superior compared to other variables, such as cigarettes per day, in the prediction of abstinence. The possibility that gender may influence this predictive relationship has not been evaluated but may be clinically useful in tailoring gender-specific interventions. Within the context of a clinical trial for smoking cessation among women, adult daily smokers completed a laboratory session that included a 1-hour ad libitum smoking period in which measures of topography were collected (N=135). Participants were then randomized to active medication (nicotine patch vs. varenicline) and abstinence was monitored for 4weeks. Among all smoking topography measures and all abstinence outcomes, a moderate association was found between longer puff duration and greater puff volume and continued smoking during the active 4-week treatment phase, but only within the nicotine patch group. Based on the weak topography-abstinence relationship among female smokers found in the current study, future studies should focus on explicit gender comparisons to examine if these associations are specific to or more robust in male smokers.
authors.affiliation: Medical University of South Carolina, Charleston, SC, USA. Electronic address: mccluree@musc.edu.
authors.forename: Erin A
authors.initials: EA
authors.lastname: McClure
authors.forename: Michael E
authors.initials: ME
authors.lastname: Saladin
authors.forename: Nathaniel L
authors.initials: NL
authors.lastname: Baker
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Carpenter
authors.forename: Kevin M
authors.initials: KM
authors.lastname: Gray
mesh_terms: D000279:Administration, Cutaneous; D000293:Adolescent; D000328:Adult; D001552:Benzazepines / Q000627:therapeutic use; D003463:Cues; D005260:Female; D006801:Humans; D008875:Middle Aged; D018722:Nicotinic Agonists / Q000627:therapeutic use; D011810:Quinoxalines / Q000627:therapeutic use; D012907:Smoking / Q000523:psychology*; D016540:Smoking Cessation / Q000523:psychology*; D000074606:Smoking Prevention; D061485:Tobacco Use Cessation Devices; D016896:Treatment Outcome; D000068580:Varenicline; D055815:Young Adult
chemical_list: D001552:Benzazepines; D018722:Nicotinic Agonists; D011810:Quinoxalines; D000068580:Varenicline
keywords: Abstinence; Gender; Smoking cessation; Smoking topography; Tobacco; Women
references.citation: Nicotine Tob Res. 2008 Jul;10(7):1245-50
references.pmid: 18629735
references.citation: Nicotine Tob Res. 1999 Dec;1(4):317-24
references.pmid: 11072428
references.citation: Am J Epidemiol. 1994 Jul 1;140(1):39-51
references.pmid: 8017402
references.citation: Clin Psychol Rev. 2006 Mar;26(2):196-215
references.pmid: 16352382
references.citation: J Consult Clin Psychol. 1999 Aug;67(4):555-62
references.pmid: 10450626
references.citation: Tob Control. 2013 Sep;22(5):356-60
references.pmid: 22649182
references.citation: Tob Control. 1997 Autumn;6(3):175-80
references.pmid: 9396100
references.citation: Addiction. 2004 Jan;99(1):29-38
references.pmid: 14678060
references.citation: Tob Control. 1997;6 Suppl 2:S57-62
references.pmid: 9583654
references.citation: Am Psychol. 1989 Nov;44(11):1355-65
references.pmid: 2589730
references.citation: Nicotine Tob Res. 2007 Mar;9(3):377-87
references.pmid: 17365769
references.citation: Nicotine Tob Res. 2002 May;4(2):149-59
references.pmid: 12028847
references.citation: Nicotine Tob Res. 2012 Apr;14(4):490-4
references.pmid: 22039077
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):154-7
references.pmid: 16434603
references.citation: MMWR Morb Mortal Wkly Rep. 2011 Nov 11;60(44):1513-9
references.pmid: 22071589
references.citation: Nicotine Tob Res. 1999 Dec;1(4):301-15
references.pmid: 11072427
references.citation: Psychopharmacology (Berl). 2002 Sep;163(2):194-201
references.pmid: 12202966
references.citation: J Consult Clin Psychol. 1995 Feb;63(1):60-9
references.pmid: 7896992
references.citation: Drug Alcohol Depend. 2009 Jan 1;99(1-3):47-57
references.pmid: 18775605
references.citation: Exp Clin Psychopharmacol. 2010 Dec;18(6):451-61
references.pmid: 21186920
references.citation: Exp Clin Psychopharmacol. 2012 Aug;20(4):251-7
references.pmid: 22545725
references.citation: Addiction. 2004 Nov;99(11):1462-9
references.pmid: 15500599
references.citation: Prev Med. 2004 Apr;38(4):498-502
references.pmid: 15020185
references.citation: Nicotine Tob Res. 2003 Feb;5(1):111-6
references.pmid: 12745512
references.citation: Nicotine Tob Res. 2012 Oct;14(10):1197-204
references.pmid: 22387995
references.citation: Cancer Epidemiol Biomarkers Prev. 2004 Nov;13(11 Pt 1):1800-4
references.pmid: 15533910
references.citation: CNS Drugs. 2001;15(5):391-411
references.pmid: 11475944
references.citation: Am J Health Behav. 2006 Jul-Aug;30(4):400-12
references.pmid: 16787130